KORELASI UMUR DENGAN KADAR HEMATOKRIT, JUMLAH LEUKOSIT, DAN TROMBOSIT PASIEN INFEKSI VIRUS DENGUE

Safari Wahyu Jatmiko

DOI: https://doi.org/10.23917/biomedika.v10i2.7024

Abstract

ABSTRAK

Infeksi virus dengue (IVD) masih menjadi masalah di negara tropis dan sub tropis. Gejala IVD dan perubahan parameter hematologi seperti jumlah leukosit, trombosit dan kadar hematokrit. pada umumnya lebih berat pada pasien infeksi sekunder dengue virus (DENV)  dengan serotipe yang berbeda. Risiko infeksi sekunder DENV meningkat seiring dengan bertambahnya usia. Hal ini menimbulkan landasan teori terhadap hipotesis bahwa semakin bertambah usia maka perubahan parameter hematologi semakin berat. Untuk menjawab hal tersebut dilakukan penelitian terhadap pasien IVD yang berusia dibawah 14 tahun dan memenuhi kriteria diagnostik WHO 2009. Diagnosis dikonfirmasi dengan IgG dan IgM antidengue. Hasil yang didapat adalah terdapat korelasi antara usia dengan kadar hematokrit dengan r = 0,248 dan p = 0,027 namun tidak ada korelasi antara usia dengan jumlah leukosit dengan r = 0,008 p = 0,943 dan trombosit  dengan r -0,01 p = 0,929. Semakin bertambah usia maka semakin berat peningkatan kadar hematokrit pada anak penderita IVD.

Kata kunci: Umur, Hematokrit, Leukosit, Trombosit, Infeksi Virus Dengue

 

ABSTRACT

Dengue virus infection (IVD) is still a problem in tropical and sub-tropical countries. Symptoms of IVD and changes in hematological parameters such as the number of leukocytes, platelets and hematocrit levels are generally more severe in secondary DENV infections with different serotypes. The risk of secondary DENV infection increases with age. This raises the theoretical basis of the hypothesis that the older the worsening changes in hematologic parameters. To address this, a study of IVD patients under 14 years old and meeting the 2009 WHO diagnostic criteria is done. The diagnosis is confirmed by IgG and IgM antidengue. The result are correlation between age with hematocrit level with r = 0,248 and p = 0,027 but no correlation between age with leukocyte count with r = 0,008 p = 0,943 and platelet with r -0,01 p = 0,929. It can be concluded that the more aged the more severe the increase in hematocrit levels in children with IVD.

Keywords: Age,  Hematocrit, Leukocyte, Platelet, Dengue Virus Infection

Full Text:

PDF

References

Azin, F.R.F.G., Gonçalves R.P., Pitombeira M.H.D., Lima D.M., Branco I.C., 2012. Dengue: profile of hematological and biochemical dynamics. Rev Bras Hematol Hemoter.34(1):36-41

Bashir, A.B., Mohammed, B.A., Saeed, O.K., and Ageep, A.K. 2015. Thrombocytopenia and Bleeding Manifestation among Patient with Dengue Virus Infection in Port Sudan, Red Sea State of Sudan. J Infect Dis Immun. 7(2):7-13

Cardozo, F. T. G. D. S., Baimukanova G., Lanteri M. C., Keating S.M., Moraes, F., Heitman, J., et al. 2017. Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro. PLoS ONE, 12(6): e0178820.

de Souzaa, L. J., Pessanha, L. B., Mansur, L. C., de Souzaa, L. A., Ribeiro, M. B. T., da Silveira, M. D. V., et al., 2013. Comparison of clinical and laboratory characteristics between children and adults with dengue. Braz J Infect Dis. 17;(1):27–31

Diamond, M. S., and Pierson, T. C., 2015. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell. 162: 488-92

Fang, C. H., Chien, Y. L., Yang, L. M.., Lu, W. J., Lin, M. F., 2015. EDTA-dependent pseudothrombocytopenia. Formosan J of Surg. 48:107-9

Fujimoto, D. E., and Koifman, S., 2014. Clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile. Rev Bras Hematol Hemoter.36(2):115-20

Ghazali, M. N. B. M., Intansari, U. S., dan Laksanawati, I. S., 2013. The Kinetics of White Blood Cells in Acute Dengue Infection. Trop Med J, 03;(1): 29-38

Gomber, S., Ramachandran, V.G., Kumar, S., Agarwal, K.N., Gupta, P., Gupta, P. et al. 2001. Hematological Observations as Diagnostic Markers in Dengue Hemorrhagic Fever - A Reappraisal. Indian Pediatric. 38:477-81

Guo, C., Zhou, Z., Wen, Z., Liu, Y., Zeng, C., Xiao, D., Ou, M., Han, Y., Huang, S., Liu, D., Ye, X., Zou, X., Wu, J., Wang, H., Zeng, E.Y., Jing, C. and Yang, G., 2017. Global Epidemiology of Dengue Outbreaks in 1990–2015: A Systematic Review and Meta-Analysis. Front. Cell. Infect. Microbiol. 7;(317):1-11

Halstead, S. B., 2012. Controversies in dengue pathogenesis. Paed Int Child Health, 32;(sup1):5-9

Halstead, S. B., 2015. Pathogenesis of Dengue: Dawn of a New Era. F1000Research. 4;(F1000 Faculty Rev):1353

Hartoyo, E. 2008. Spektrum Klinis Demam Berdarah Dengue pada anak. Sari Pediatri, 10(3):145-50

Her, hisheng., Kam, Y. W., Gan, V. C., Lee, B., Thein, T. L., Tan, J. J. L., et al., 2017. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ–Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection. J Infect Dis, 215:42–51

Jakribettu, R. P., Boloor, R., Thaliath, A., George, S. Y., George, T., Rai, M. P., et al., 2015. Correlation of Clinicohaematological Parameters in Paediatric Dengue: A Retrospective Study. J Trop Med. 647162:1-7

Jatmiko, S.W. 2016. Hubungan Kadar Rheumatoid Factor dengan Perubahan Jumlah Trombosit dan Nilai Hematokrit pada Anak Terinfeksi Virus Dengue. Semarang: Universitas Diponegoro (Thesis). 1-58

Jatmiko, SW. 2017. Status Serologis Tidak Mempengaruhi Profil Hematologi Anak Terinfeksi Virus Dengue. Biomedika, 9;(1):50-4

Jatmiko, S.W., Suromo, L., Dharmana, E., 2017. IgM-RF pada Anak Terinfeksi Virus Dengue Tidak Berkorelasi dengan Jumlah Trombosit dan Hematokrit. JKB, 29;(4):306-11

Joshi AA, Divyashree BN, Gayathri BR. 2018. The Hematocrit Spectrum in Dengue. Int J Sci Stud;5(10):1-5

Joshi, Anagha A., Gayathri B. R., Gowda R, Yashica., 2017. The total leucocyte count: its utility in dengue. Int J Adv Med.4;(6):1621-6

Karyanti, M. R., Uiterwaal, C. S. P. M., Kusriastuti, R., Hadinegoro, S. R., Rovers, M. M., Heesterbeek, H., Hoes, A. W., Bruijning-Verhagen, P., 2014. The changing incidence of Dengue Haemorrhagic Fever in Indonesia: a 45-year registry-based analysis.

BMC Infect Dis,14:412

Khandelwal, R., Khandelwal, L.M., 2017. Effect of dengue fever on the total leucocyte count and neutrophil count in children in early febrile period. Int J Ped Res, 4;(10): 617-22

Kosasih, H., Alisjahbana, B., Nurhayati , de Mast, Q., Rudiman, I.F., Widjaja, S., et al. 2016. The Epidemiology, Virology and Clinical Findings of Dengue Virus Infections in a Cohort of Indonesian Adults in Western Java. PLoS Negl Trop Dis. 10;(2): e0004390.

Krishnamurthy, V., Rajashekar, R., Doreswamy, S. M., 2016. Peripheral cell line suppression in dengue infection in relation to serological status. Asian Journal of Medical Sciences. 7(5):

Kuo, H. J., Lee, I. K., Liu, J. W., 2017. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly, J Microbiol Immunol Infect. article in press

Khurram, M., Qayyum, W., Hassan, S. J., Mumtaz, S., Bushra, H. T., Umar, M., 2014. Dengue hemorrhagic fever: Comparison of patients with primary and secondary infections. J Infect Public Health. 7:489-95

Malavige, G. N., Fernando, N., Ogg, G., 2011. Pathogenesis of Dengue viral infections. Sri Lankan J Infect Dis.1;(1): 2-8

Pan, S. T,. Su, P. A., Chen, K. T.., Lin, H. J., Lai, W. P., 2014. Comparison of the clinical manifestations exhibited by dengue and nondengue patients among children in a medical center in southern Taiwan. J Acute Med. 4:53-6

Simmons, C. P., McPherson, K., Chau, N.V. V., Tame, D.T. H., Young, P., Mackenzie, J., et al., 2015. Recent advances in dengue pathogenesis and clinical management. Vaccine. 33:7061–8

Stanaway, J. D., Shepard, D. S., Undurraga, E. A., Halasa, Y. A., Coffeng, L. E., Brady, O. J., Hay, S. I. Bedi, N., Bensenor, I. M., Castañeda-Orjuela, C. A., et al., 2016. The Global Burden of Dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 16;(6):712–23

Thai, K.T.D., Nishiura, H., Hoang, P.L., Tran, N.T.T., Phan, G.T., Le, H.Q., et al. 2011 Age-Specificity of Clinical Dengue during Primary and Secondary Infections. PLoS Negl Trop Dis, 5;(6):e1180.

Tsai, J. J., Chang, J. S., Chang, K., Chen, P. C., Liu, L. T., Ho, T. C, et al., 2017. Transient Monocytosis Subjugates Low Platelet Count in Adult Dengue Patients. Biomed Hub, 2;(457785):1-16

Wahyono, T. Y. M., Nealon, J., Beucher, S., Prayitno, A., Moureau, A., Nawawi, S., Thabrany, H., Nadjib, M., 2017. Indonesian dengue burden estimates: review of evidence by an expert panel. Epidemiol. Infect. 145:2324–9

Wiwanitkit, V, and Manusvanich, P. 2004. Can hematocrit and platelet determination on admission predict shock in hospitalized children with dengue hemorrhagic fever? A clinical observation from a small outbreak. Clin Appl Thromb Hemost. 10(1):65-7

Yacoub, S. and Wills, B., 2014. Predicting outcome from dengue. BMC Med, 12(147):1-10

Refbacks

  • There are currently no refbacks.